Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Gene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cells. / Potter, Ekaterina A.; Dolgova, Evgenia V.; Proskurina, Anastasia S. и др.
в: Oncotarget, Том 8, № 6, 07.02.2017, стр. 9425-9441.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Gene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cells
AU - Potter, Ekaterina A.
AU - Dolgova, Evgenia V.
AU - Proskurina, Anastasia S.
AU - Efremov, Yaroslav R.
AU - Minkevich, Alexandra M.
AU - Rozanov, Aleksey S.
AU - Peltek, Sergey E.
AU - Nikolin, Valeriy P.
AU - Popova, Nelly A.
AU - Seledtsov, Igor A.
AU - Molodtsov, Vladimir V.
AU - Zavyalov, Evgeniy L.
AU - Taranov, Oleg S.
AU - Baiborodin, Sergey I.
AU - Ostanin, Alexander A.
AU - Chernykh, Elena R.
AU - Kolchanov, Nikolay A.
AU - Bogachev, Sergey S.
PY - 2017/2/7
Y1 - 2017/2/7
N2 - Using the ability of poorly differentiated cells to natively internalize fragments of extracellular double-stranded DNA as a marker, we isolated a tumorigenic subpopulation present in Krebs-2 ascites that demonstrated the features of tumor-inducing cancer stem cells. Having combined TAMRA-labeled DNA probe and the power of RNA-seq technology, we identified a set of 168 genes specifically expressed in TAMRA-positive cells (tumor-initiating stem cells), these genes remaining silent in TAMRA-negative cancer cells. TAMRA+ cells displayed gene expression signatures characteristic of both stem cells and cancer cells. The observed expression differences between TAMRA+ and TAMRA- cells were validated by Real Time PCR. The results obtained corroborated the biological data that TAMRA+ murine Krebs-2 tumor cells are tumor-initiating stem cells. The approach developed can be applied to profile any poorly differentiated cell types that are capable of immanent internalization of double-stranded DNA.
AB - Using the ability of poorly differentiated cells to natively internalize fragments of extracellular double-stranded DNA as a marker, we isolated a tumorigenic subpopulation present in Krebs-2 ascites that demonstrated the features of tumor-inducing cancer stem cells. Having combined TAMRA-labeled DNA probe and the power of RNA-seq technology, we identified a set of 168 genes specifically expressed in TAMRA-positive cells (tumor-initiating stem cells), these genes remaining silent in TAMRA-negative cancer cells. TAMRA+ cells displayed gene expression signatures characteristic of both stem cells and cancer cells. The observed expression differences between TAMRA+ and TAMRA- cells were validated by Real Time PCR. The results obtained corroborated the biological data that TAMRA+ murine Krebs-2 tumor cells are tumor-initiating stem cells. The approach developed can be applied to profile any poorly differentiated cell types that are capable of immanent internalization of double-stranded DNA.
KW - DNA internalization
KW - Real Time PCR
KW - RNAseq
KW - TAMRA
KW - Tumor-initiating stem cells
KW - Gene Expression Profiling/methods
KW - Rhodamines/metabolism
KW - Signal Transduction
KW - Gene Expression Regulation, Neoplastic
KW - Neoplastic Stem Cells/metabolism
KW - Transcriptome
KW - Carcinoma, Krebs 2/genetics
KW - Gene Regulatory Networks
KW - Biomarkers, Tumor/genetics
KW - DNA/genetics
KW - Phenotype
KW - Animals
KW - Sequence Analysis, RNA
KW - Cell Differentiation
KW - High-Throughput Nucleotide Sequencing
KW - Fluorescent Dyes/metabolism
KW - Alu Elements
KW - Real-Time Polymerase Chain Reaction
KW - SIGNALING PATHWAYS
KW - COLONY-STIMULATING FACTOR
KW - DRUG-RESISTANCE
KW - BREAST-CANCER
KW - IN-VITRO
KW - tumor-initiating stem cells
KW - PROSTATE-CANCER
KW - ANTIAPOPTOTIC GENES
KW - CANCER-ASSOCIATED FIBROBLASTS
KW - SELF-RENEWAL
KW - ACUTE MYELOID-LEUKEMIA
UR - http://www.scopus.com/inward/record.url?scp=85012025889&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.14116
DO - 10.18632/oncotarget.14116
M3 - Article
C2 - 28031533
AN - SCOPUS:85012025889
VL - 8
SP - 9425
EP - 9441
JO - Oncotarget
JF - Oncotarget
SN - 1949-2553
IS - 6
ER -
ID: 10311690